| Theme |
Stenting for Digestive Diseases |
| Title |
Self-expandable Metallic Stent for Colorectal Stenosis |
| Author |
Akihisa Matsuda |
Department of Gastrointestinal and Hepato‒Biliary‒Pancreatic Surgery, Nippon Medical School |
| Author |
Takashi Yamada |
Department of Gastrointestinal and Hepato‒Biliary‒Pancreatic Surgery, Nippon Medical School |
| Author |
Satoshi Matsumoto |
Department of Surgery, Nippon Medical School Chiba Hokusoh Hospital |
| Author |
Takahiro Koizumi |
Department of Gastrointestinal and Hepato‒Biliary‒Pancreatic Surgery, Nippon Medical School |
| Author |
Seiichi Shinji |
Department of Gastrointestinal and Hepato‒Biliary‒Pancreatic Surgery, Nippon Medical School |
| Author |
Ryu Ohta |
Department of Gastrointestinal and Hepato‒Biliary‒Pancreatic Surgery, Nippon Medical School |
| Author |
Goro Takahashi |
Department of Gastrointestinal and Hepato‒Biliary‒Pancreatic Surgery, Nippon Medical School |
| Author |
Keisuke Hara |
Department of Gastrointestinal and Hepato‒Biliary‒Pancreatic Surgery, Nippon Medical School |
| Author |
Hiroshi Yoshida |
Department of Gastrointestinal and Hepato‒Biliary‒Pancreatic Surgery, Nippon Medical School |
| [ Summary ] |
After the coverage of health insurance in 2012, 4 types of colonic self-expandable metallic stents (SEMS) are currently available in Japan for the management of malignant large bowel obstruction (MLBO). Thorough knowledge of the appropriate manipulation and usage and characteristics of each type of SEMS is important for procedural safety when using these devices. SEMS are preferred for palliative treatment, based on clinical guidelines. However, the efficacy of preoperative stent placement (bridge to surgery: BTS) is unclear owing to lack of studies reporting long-term results as supporting evidence. Previous studies have shown that short-term results associated with SEMS usage are better than those observed with a transanal decompression tube, including decompression device- and surgery induced outcomes. Future studies are warranted to evaluate the safety of chemotherapy in patients undergoing palliative SEMS placement. SEMS is a promising treatment option for the management of patients with MLBO. |